Houston Rockets enter 2026-27 as a dangerous Western Conference sleeper
The Houston Rockets are viewed as a tough playoff opponent despite recent disappointment, with their outlook tied to the health of Steven Adams and Fred VanVleet. Adams’ season-ending injury hurt Houston’s offensive rebounding and overall efficiency, and the team struggled without its two most important players. If healthy, the Rockets could avoid the fate of recent Sacramento teams that peaked early and faded.
Houston’s outlook hinges on Steven Adams and Fred VanVleet. Adams missed the rest of the season, and the club’s offensive, defensive, and net ratings dropped from third, seventh, and fourth to 14th, ninth, and 11th. His rebounding created extra possessions; when he played, Houston ranked in the 100th percentile in offensive rebound rate.
VanVleet sat out the whole year after an ACL tear. In a 2025 playoff series against Golden State, Houston’s offense dipped by 28.1 points per 100 possessions while he sat. The pair appeared in only 32 combined games; that total is likely to rise in 2026-27.
The health of Adams and VanVleet could shape how competitive Houston is, which may affect fans, teammates, coaches, and team staff. A healthier roster might restore playoff excitement and local game-day spending, while another injury-hit season could frustrate supporters and alter expectations around young players’ development. For the wider NBA, Houston’s rise or fall may influence Western Conference storylines and how analysts judge teams built around physical rebounding and veteran playmaking. These outcomes remain uncertain and depend on medical recovery, roster cohesion, and performance.